SCHEMBL30680157

SCHEMBL30680157

CC(C)(C)OC(=O)N1CCC2(CC1)CN(c1ncnc(N)c1I)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.47
▸ KIT P10721 2/20 0.45
▸ HDAC2 Q92769 2/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ CYP11B2 P19099 1/20 0.41
▸ ACACB O00763 4/20 0.41
▸ ADK P55263 1/20 0.41
▸ SCD5 Q86SK9 1/20 0.40
▸ JAK3 P52333 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ SMARCA2 P51531 1/20 0.40
▸ SMARCA4 P51532 1/20 0.40
▸ PBRM1 Q86U86 1/20 0.40
▸ GPR119 Q8TDV5 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ PIK3R1 P27986 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24772750 1.00 MAP4K4 (0.47) MAP4K4KITHDAC2HDAC1CYP11B2
SCHEMBL30406162 0.78 KIT (0.52) MAP4K4KITCYP11B2SCD5JAK3
SCHEMBL30456119 0.77 KIT (0.49) KITCYP11B2SCD5JAK3CYP3A4
SCHEMBL15728505 0.76 MAP4K4 (0.61) MAP4K4KITADKALDH1A1SMARCA2
SCHEMBL30405762 0.75 HTT (0.49) MAP4K4KITHDAC2HDAC1CYP11B2
SCHEMBL25422069 0.75 HTT (0.49) MAP4K4KITHDAC2HDAC1CYP11B2
SCHEMBL25270429 0.75 KIT (0.45) KITHDAC2HDAC1CYP11B2ACACB
SCHEMBL31579068 0.74 MAP4K4 (0.43) MAP4K4KITHDAC2HDAC1CYP11B2
SCHEMBL18291310 0.74 CYP3A4 (0.47) HDAC2HDAC1CYP11B2ACACBSCD5
SCHEMBL30664043 0.74 CYP3A4 (0.47) HDAC2HDAC1CYP11B2ACACBSCD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117222640-A Heterocyclic compounds as FGFR inhibitors and uses thereof 先声再明医药有限公司 2023-12-12 — — CN disclosed
Send feedback